Structure |
Chemical Name |
CAS |
MF |
|
Crisaborole Impurity ABCDEFGHJKL |
|
|
|
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |
|
3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide |
2511244-97-4 |
C27H36N2O6 |
|
2,4,6,3',5'-pentamethoxybiphenyl |
84212-55-5 |
C17H20O5 |
|
Labetalol EP Impurity I |
|
|
|
(Asp4)-Carbetocin (Impurity G) |
|
|
|
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
|
methyl 3-oxo1,2-benzisothiazole-2(3H)-acetate 1,1-dioxide |
6639-62-9 |
C10H9NO5S |
|
(6R-cis)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-(2-thienylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
54333-94-7 |
C15H16N2O6S2 |
|
5-acetyl-1,3-phenylene bis(dimethylcarbamate) |
81732-48-1 |
C14H18N2O5 |
|
Oseltamivir Impurity L |
|
|
|
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
|
2-(N,N-DIETHYLAMINO)-4,6-DICHLOROTRIAZINE |
2401-64-1 |
C5H6Cl2N4 |
|
(S)-4-Chloro-1,3-butanediol |
139013-68-6 |
C4H9ClO2 |
|
6-CHLORO-1-METHYLURACIL |
31737-09-4 |
C5H5ClN2O2 |
|
5-(Propylthio)-1H-benzimidazol-2-amine |
80983-36-4 |
C10H13N3S |
|
Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate |
179688-26-7 |
C15H21NO8 |
|
Hexyl methanesulfonate |
16156-50-6 |
C7H16O3S |
|
2-[(5-CARBOXY-4-METHOXY-3-METHYLPYRID-2-YL)-METHYLSULFO]-5-METHOXYBENZIMIDAZOLE |
120003-72-7 |
C17H17N3O5S |
|
Gadobutrol Impurity 3 |
|
|
|
Empagliflozin Impurity 84 |
|
|
|
Iohexol Impurity O |
|
|
|
Avibactam sodium Impurity CES |
|
|
|
(2,5-dichlorophenyl)(4-ethoxyphenyl)methanone |
1097076-93-1 |
C15H12Cl2O2 |
|
Lenvatinib impurity LFZZ-10 |
|
C11H8Cl2N2O2 |
|
(2S,5S)-(1R,2S,5R)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate |
|
|
|
Febuxostat Impurity 98 |
|
|
|
(2-(methyl((vinyloxy)carbonyl)amino)pyridin-3-yl)methyl 2-(methylamino)acetate hydrochloride |
|
|
|
1-(4-bromo-3,5-dimethoxyphenyl)ethanone |
1333472-28-8 |
C10H11BrO3 |
|
Ticagrelor Impurity 117 |
|
|
|
Ticagrelor Impurity 136 |
|
|
|
Phenol, 2-(diphenylmethyl)-5-methyl- |
411239-19-5 |
C20H18O |
|
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-(formylamino)-, ethyl ester, (3R,4R,5S)- |
2148317-96-6 |
C17H28N2O5 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-(5-chloro-2-ethoxyphenyl)-5-methyl-7-propyl- |
2245167-80-8 |
C17H19ClN4O2 |
|
Posaconazole impurity 18 |
1819334-66-1 |
C44H49F2N8O4+ |
|
(4S,6R)-6-(2-(tert-butoxy)-2-oxoethyl)-2,2-dimethyl-1,3-dioxane-4-carboxylic acid |
2095786-11-9 |
C13H22O6 |
|
Crisaborole intermediate |
2354382-27-5 |
C14H8BCl2NO3 |
|
Ropivacaine Impurity 48 |
|
|
|
2,4-Heptadienoic acid, 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-, (2Z,4E)- |
1148131-09-2 |
C33H31FN2O3 |
|
2(3H)-Furanone, dihydro-4-(1-methylethyl)-, (4S)- |
53657-15-1 |
C7H12O2 |
|
Crisaborole Impurity 9 HCl |
1187187-01-4 |
C14H15BClNO3 |
|
2H-Indol-2-one, 3-[[3,5-dimethyl-4-(1-pyrrolidinylcarbonyl)-1H-pyrrol-2-yl]methylene]-5-fluoro-1,3-dihydro- |
2135339-43-2 |
C20H20FN3O2 |
|
Nicergoline Impurity 02 |
|
|
|
5-CHLOROTHIOPHENE-3-CARBOXYLIC ACID |
36157-42-3 |
C5H3ClO2S |
|
(S)-(+)-1-[(4-Chlorophenyl)phenylmethyl]piperazine |
439858-21-6 |
C17H19ClN2 |
|
2,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-β]pyridin-11-one |
133330-61-7 |
C14H9Cl2NO |
|
2-Isopropyl-6-propylphenol (Propofol Impurity O) |
74663-48-2 |
C12H18O |
|
3-Methyl-2-(3,4-dimethoxyphenyl)butyronitrile |
20850-49-1 |
C13H17NO2 |
|
HYDROXY ITRACONAZOLE |
112559-91-8 |
C35H38Cl2N8O5 |
|
1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE |
170569-87-6 |
C16H12F3N3O2S |
|
N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide |
1038972-16-5 |
C13H18N4O3 |
|
1,4-BIS[3,4-DIHYDRO-2(1H)-QUINOLINON-7-OXY]BUTANE |
882880-12-8 |
C22H24N2O4 |
|
(R)-SN-38 |
647852-82-2 |
C22H20N2O5 |
|
5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine |
162204-30-0 |
C15H22FN3O6 |
|
Bromhexine ImpurityABCDEFGHJKL |
|
|
|
1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- |
1576240-16-8 |
C24H28FN3O |
|
impurity 37 |
|
|
|
Aprepitant impurity 3 |
|
|
|
sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
|
1,4,7,10-Tetraazacyclododecane-1,4-diacetic acid |
229312-34-9 |
C12H24N4O4 |
|
Pentanoic acid, 3-(bromomethyl)-4-methyl-, ethyl ester, (3S)- |
2432911-38-9 |
C9H17BrO2 |
|
Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[(4-ethyl-1-piperazinyl)sulfonyl]-2-hydroxyphenyl]-5-methyl-7-propyl- |
2411340-39-9 |
C21H28N6O4S |
|
3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-[4-[7-(hydroxymethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-1H-pyrazol-1-yl]- |
1187595-89-6 |
C17H19N7O3S |
|
4-methyl-N-(2-(methylamino)phenyl)-2-propyl-1H-benzo[d]imidazole-6-carboxamide |
884330-18-1 |
C19H22N4O |
|
Benzeneacetic acid, 3-(2-amino-1,1-dimethyl-2-oxoethyl)-α,α-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- |
2469244-33-3 |
C17H22N4O3 |
|
2,4(1H,3H)-Pyrimidinedione, 5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-3-[(2R)-2-(hydroxyamino)-2-phenylethyl]-6-methyl- |
2486454-64-0 |
C28H24F5N3O4 |
|
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-hydroxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-94-0 |
C24H25Cl2N5O3 |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-, (6bR,10aS)- |
313368-81-9 |
C13H17N3 |
|
Ergoline-8-methanol, 1,6-dimethyl-, (8β)- (9CI) |
40170-12-5 |
C17H22N2O |
|
Avatrombopag Impurity 22 |
|
|
|
Avatrombopag Impurity 33 |
|
|
|
Cisatracurium besylate impurity 16 |
|
|
|
1-ACETYL-2-METHYLBENZIMIDAZOLE |
14678-81-0 |
C10H10N2O |
|
(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester |
103890-69-3 |
C14H16O3 |
|
1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)- |
1046533-62-3 |
C33H33FN2O6 |
|
Bimatoprost Impurity 22 |
|
|
|
Bumetanide Impurity 9 |
|
|
|
Crisaborole Impurity 14 |
|
|
|
Benzonitrile, 4-[(1E)-4-(dimethylamino)-1-(4-fluorophenyl)-1-buten-1-yl]-3-(hydroxymethyl)- |
1370643-23-4 |
C20H21FN2O |
|
Latamoxef impurity B |
|
|
|
(9alpha,13alpha,14alpha)-3-methoxymorphinan-17-carbaldehyde |
28973-48-0 |
C18H23NO2 |
|
(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-56-8 |
C23H29NO4 |
|
Alogliptin Impurity A |
|
|
|
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
|
Parecoxib Impurity C |
|
|
|
Rac Atomoxetine Hydrochloride |
82857-40-7 |
C17H22ClNO |
|
3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
943320-48-7 |
C10H8F3N3 |
|
Linagliptin Impurity H |
1646355-34-1 |
C22H23N7O2 |
|
Ezetimibe Impurity 54 |
1185883-39-9 |
C40H36F2N2O5 |
|
2-(2-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
1348664-75-4 |
C13H13FN6O |
|
Dapagliflozin Impurity 2 |
|
|
|
Imatinib Impurity 1 |
|
|
|
Imatinib Impurity 6 |
|
|
|
Nifedipine Impurity 3 |
|
C19H22N2O6 |
|
Riociguat Impurtiy 5 |
|
|
|
Vonoprazan Impurity 6 |
|
|
|
Avibactam Impurity |
1797133-98-2 |
C7H12N3NaO6S |
|
Citalopram EP Impurity E |
64169-47-7 |
C19H22Cl2FNO |
|
Dapagliflozin Impurity F |
|
|
|
Dapoxetine Impurity A |
|
|